Some studies have suggested that polymorphisms in the NR3C1 gene may indirectly affect the metabolism and transport of epilepsy drugs by affecting the function of the hypothalamic–pituitary–adrenal axis (HPA) [31]. Here, NR3C1 is linked to epilepsy.